← Leaderboards
Seth Y Ablordeppey
Florida Agricultural And Mechanical Univ
$7,414,877
Attributed
$7,414,877
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,640,432 · 11
By mechanism
U54$3,738,526 · 2
SC1$2,552,373 · 2
G12$2,458,923 · 4
R25$1,100,051 · 1
R16$790,559 · 1
S06$0 · 1
Top collaborators
- Chanita A Hughes-Halbert4 shared
- Romonia Renee Reams4 shared
- Mariana C Stern4 shared
- Diana J Wilkie4 shared
Most similar at Florida Agricultural And Mechanical Univ
Same institution · by research overlap
- Romonia Renee Reams$3,229,685
- Kinfe Ken Redda$5,794,556
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignEvaluationIn VivoLeadAmericanAffinityReportingGrantNew AgentsBiological AvailabilityPharmaceutical PreparationsReceptorCharacteristicsDrug KineticsBeta-ArrestinSignal TransductionPublishingMetabolicGtp-Binding ProteinsPharmacologyScientistUniversitiesRecruitPermeability
Grant awards (37)
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Center$1,023,664
U54 · FY2025 · CA
Research Project-2: Functionally Selective Ligands Targeting 5-HT7 Receptor as Potential Antinociceptive Agents$262,751
U54 · FY2025 · MD · contact PI
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist$148,000
R16 · FY2025 · GM · contact PI
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$972,480
U54 · FY2024 · CA
Research Project-2: Functionally Selective Ligands Targeting 5-HT7 Receptor as Potential Antinociceptive Agents$250,220
U54 · FY2024 · MD · contact PI
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$236,349
U54 · FY2024 · CA
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist$148,000
R16 · FY2024 · GM · contact PI
Instrument Supplemental Grant$99,488
R16 · FY2024 · GM · contact PI
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center$993,062
U54 · FY2023 · CA
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist$148,000
R16 · FY2023 · GM · contact PI
Supplement to Discovery of a high affinity, selective and beta-arrestinbiased 5-HT7R Agonist Grant$99,071
R16 · FY2023 · GM · contact PI
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist$148,000
R16 · FY2022 · GM · contact PI
CREATE (Center for Research, Education and Training Enhancement)$493,017
R25 · FY2019 · GM · contact PI
A New Approach for the Development of Novel Antipsychotic Drugs$370,000
SC1 · FY2019 · GM · contact PI
A New Approach for the Development of Novel Antipsychotic Drugs$370,000
SC1 · FY2018 · GM · contact PI
CREATE (Center for Research, Education and Training Enhancement)$303,017
R25 · FY2018 · GM · contact PI
A New Approach for the Development of Novel Antipsychotic Drugs$333,534
SC1 · FY2017 · GM · contact PI
CREATE (Center for Research, Education and Training Enhancement)$304,017
R25 · FY2017 · GM · contact PI
A New Approach for the Development of Novel Antipsychotic Drugs$337,755
SC1 · FY2016 · GM · contact PI
Development of Novel Agents for CNS-related Diseases$251,213
SC1 · FY2012 · GM · contact PI
Development of Novel Agents for CNS-related Diseases$251,213
SC1 · FY2011 · GM · contact PI
Development of Novel Agents for CNS-related Diseases$305,750
SC1 · FY2010 · GM · contact PI
Development of Novel Agents for CNS-related Diseases$332,908
SC1 · FY2009 · GM · contact PI
DDR SUBPROJ 2:BENZOTHIENOQUINOLINES AS NOVEL ANTIFUNGAL AGENTS IN AIDS-RELATED$258,409
G12 · FY2008 · RR · contact PI
DDR SUBPROJ 2:BENZOTHIENOQUINOLINES AS NOVEL ANTIFUNGAL AGENTS IN AIDS-RELATED$109,693
G12 · FY2007 · RR · contact PI
DDR SUBPROJ 2:BENZOTHIENOQUINOLINES AS NOVEL ANTIFUNGAL AGENTS IN AIDS-RELATED$122,521
G12 · FY2006 · RR · contact PI
DDR SUBPROJ 2:BENZOTHIENOQUINOLINES AS NOVEL ANTIFUNGAL AGENTS IN AIDS-RELATED$106,829
G12 · FY2005 · RR
BENZOTHIENOQUINOLINES AS NOVEL ANTIFUNGAL AGENTS$149,356
G12 · FY2004 · RR
STRUCTURE ACTIVITY STUDIES OF NOVEL ANTIFUNGAL AGENTS AGAINST OI ASSOC W/ AIDS$382,503
G12 · FY2002 · RR
STRUCTURE ACTIVITY STUDIES OF NOVEL ANTIFUNGAL AGENTS AGAINST OI ASSOC W/ AIDS$382,503
G12 · FY2002 · RR
METABOLISM BASED DRUG DESIGN--EVALUATION OF HALOPERIDOL AGENTS$0
S06 · FY2002 · GM
METABOLISM BASED DRUG DESIGN--EVALUATION OF HALOPERIDOL AGENTS$0
S06 · FY2002 · GM
STRUCTURE ACTIVITY STUDIES OF NOVEL ANTIFUNGAL AGENTS AGAINST OI ASSOC W/ AIDS$382,503
G12 · FY2001 · RR
Metabolism-Based Drug Design &Evaluation of Haloperidol$0
S06 · FY2001 · GM
METABOLISM BASED DRUG DESIGN--EVALUATION OF HALOPERIDOL AGENTS$0
S06 · FY2001 · GM
STRUCTURE ACTIVITY STUDIES OF NOVEL ANTIFUNGAL AGENTS AGAINST OI ASSOC W/ AIDS$0
G12 · FY2001 · RR
STRUCTURE ACTIVITY STUDIES OF NOVEL ANTIFUNGAL AGENTS AGAINST OI ASSOC W/ AIDS$564,606
G12 · FY2000 · RR